Single-neuron tracking captures psilocybin’s split-second and day-later effects
A preclinical study using chronically implanted Neuropixels probes found that psilocybin altered neuronal firing both immediately after dosing and again 24 hours later in mice, offering rare cell-by-cell evidence that the drug’s influence outlasts its presence in the body. Investigators tracked 1,692 neurons across prefrontal and hippocampal regions after saline and psilocybin injections, then returned to the same neural population a day later to see which cells had recovered and which had not. The design matters because psilocybin’s psychiatric effects are often described as rapid yet durable, and the circuitry behind that durability has been difficult to observe directly.
The acute response was not uniform. Firing changed in both directions, depending on cell type and brain region, which is consistent with a compound acting through serotonergic signaling in tightly interconnected cortical and limbic circuits rather than simply turning brain activity up or down. Some neurons were activated, others suppressed, and the effect pattern varied across the prefrontal cortex and hippocampus. The study also separated the earliest peak response from the later acute phase, and only the late acute response carried predictive value for what happened 24 hours later.
That pattern points to a biological distinction between a transient pharmacologic surge and the neural state that follows it.
Persistent suppression at 24 hours did not mirror the acute spike
By 24 hours after injection, neuronal firing was net suppressed relative to saline, including among neurons that had been acutely activated. This is the most striking result in the dataset because it shows that a brief psychedelic exposure leaves behind a measurable shift in baseline excitability long after systemic exposure has ended. The finding also argues against a simple rebound model in which neurons return cleanly to baseline once the drug clears. Instead, the brain appears to settle into a lower-firing state across a subset of recorded cells, even after an initial burst of activity.
That persistent suppression could reflect altered excitatory-inhibitory balance, changes in synaptic gain, or a short-lived remodeling of ensemble dynamics after serotonergic stimulation. Psilocybin is known to engage plasticity-related pathways in animal models, and reduced firing a day later may represent one electrophysiologic expression of that plasticity. In practical terms, the data suggest that the biologic footprint of a psychedelic dose is not confined to the minutes or hours when the drug is detectable. It reaches into the next day at the level of single neurons.
Late acute firing best predicted the next-day state
The strongest predictive signal came from the late acute response, not the early peak response. In other words, the neural activity that emerged after the first rapid surge appeared more informative about the future firing state than the initial spike itself. That detail may seem technical, but it speaks directly to how psilocybin reorganizes circuits: the first moment of receptor engagement may not be the most important. The later acute period may capture a stabilization phase, when downstream network effects, receptor dynamics, and emergent circuit interactions begin to dominate.
This is precisely the kind of information that single-cell tracking can reveal and conventional snapshot experiments cannot. Without recording the same neurons across time, it would be impossible to tell whether the 24-hour suppression arose from a different set of cells or from neurons that were already pushed in a particular direction during the acute response. Here, the same cells were followed across both periods, making the persistent effect much harder to dismiss as a sampling artifact.
Why prefrontal and hippocampal circuits matter for psychedelic biology
The prefrontal cortex and hippocampus sit at the center of cognition, memory, and affective regulation, all of which are relevant to psychedelic treatment hypotheses. Changes in firing within these regions could help explain why psilocybin has been linked to altered cognition, changed emotional processing, and prolonged behavioral effects in animal and human studies. When serotonergic input disrupts and then reconfigures activity in these networks, the downstream result may be a temporary loosening of entrenched firing patterns followed by a new baseline state.
That possibility fits with the broader idea that psilocybin does not merely produce an acute subjective state; it may also open a short window during which neural circuits become more plastic or more malleable. The present study does not prove that mechanism, but it does provide direct electrophysiologic evidence that the drug leaves a durable mark on neuronal activity after the acute exposure window closes. Because the data came from chronically implanted probes, the study avoids a major limitation of short-lived recordings, where the same neuron cannot be revisited later to determine whether the effect persisted.
What the preprint can and cannot support
This was a mouse study, and the findings should not be treated as direct evidence of the human therapeutic mechanism. The experiments were also reported as a bioRxiv preprint and have not yet undergone peer review, so the conclusions remain provisional. Even so, the dataset is unusually strong for a mechanistic neuroscience question because it links acute and persistent responses in the same neurons across days. That makes the central observation difficult to ignore: psilocybin’s effect on firing outlasts the drug’s immediate systemic presence.
The study stops short of explaining which receptor populations or intracellular pathways drive the day-later suppression. It also does not establish how these firing changes map onto behavior, cognition, or antidepressant-like effects in the animals. Those questions remain open, and they will matter for translation. A mechanistic bridge from altered single-neuron firing to durable clinical benefit still has to be built, and this preprint provides only part of that structure.
For now, the key contribution is concrete and narrowly defined. Psilocybin altered neurons acutely, and the next-day state was not a simple return to baseline. The late acute phase predicted that persistent shift, suggesting that the path from psychedelic exposure to lasting circuit change may be traced in the firing patterns that emerge after the initial peak has passed.
- • bioRxiv preprint DOI 10.64898/2026.11.14.766632: https://doi.org/10.64898/2026.11.14.766632